Literature DB >> 28554354

Association Between Acute Pain and Hemodynamic Parameters in a Postoperative Surgical Intensive Care Unit.

Hossein Asgar Pour.   

Abstract

I conducted a prospective repeated-measure study in the general surgery intensive care unit to investigate the associations among acute postoperative pain, analgesic therapy, and hemodynamic parameters. I selected 33 patients and recorded 84 episodes of pain. I measured intensity of pain and hemodynamic parameters after patients were transferred from the postanesthesia care unit to the general surgery intensive care unit, immediately before analgesic therapy and at 15, 30, and 45 minutes after analgesic therapy. Acute pain increased systolic (SBP), diastolic (DBP), and mean arterial blood pressure (MAP); pulse rate (PR); and arterial oxygen saturation. Fifteen minutes after analgesic therapy, SBP and PR decreased, and DBP, MAP, and oxygen saturation increased. Thirty minutes after therapy, SBP, MAP, and PR decreased, and DBP and oxygen saturation increased. Forty-five minutes after therapy, SBP, MAP, and PR decreased, and DBP and oxygen saturation increased. I saw no significant hemodynamic parameter changes during postoperative episodes of pain.
Copyright © 2017 AORN, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute pain; analgesic therapy; hemodynamic parameters; postoperative pain

Mesh:

Substances:

Year:  2017        PMID: 28554354     DOI: 10.1016/j.aorn.2017.04.006

Source DB:  PubMed          Journal:  AORN J        ISSN: 0001-2092            Impact factor:   0.676


  2 in total

1.  Acute Pain Assessment in Sedated Patients in the Postanesthesia Care Unit.

Authors:  Sherily Pereira-Morales; Carmen Mabel Arroyo-Novoa; Annette Wysocki; Lucille Sanzero Eller
Journal:  Clin J Pain       Date:  2018-08       Impact factor: 3.442

Review 2.  Pain measurement techniques: spotlight on mechanically ventilated patients.

Authors:  Isabela Freire Azevedo-Santos; Josimari Melo DeSantana
Journal:  J Pain Res       Date:  2018-11-21       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.